Historical prostate cancer screening and treatment outcomes from a single institution

about

Current status of biomarkers for prostate cancer Heart healthy equals prostate healthy and statins, aspirin, and/or metformin (S.A.M.) are the ideal recommendations for prostate cancer prevention

P2860

Q24600574-55EE1F47-248E-43F5-B051-9AA2E643AF91 Q36080332-8A4C78F5-3A01-4BE2-BDBA-64288D0A6B72

P2860

Historical prostate cancer screening and treatment outcomes from a single institution

Item

http://www.wikidata.org/entity/Q36170995

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Historical prostate cancer screening and treatment outcomes from a single institution

@ast

Historical prostate cancer screening and treatment outcomes from a single institution

@en

type

Item

label

Historical prostate cancer screening and treatment outcomes from a single institution

@ast

Historical prostate cancer screening and treatment outcomes from a single institution

@en

prefLabel

Historical prostate cancer screening and treatment outcomes from a single institution

@ast

Historical prostate cancer screening and treatment outcomes from a single institution

@en

P1476

Historical prostate cancer screening and treatment outcomes from a single institution

@en

P2093

Deanna S Cross

http://www.w3.org/2001/XMLSchema#string

Douglas J Reding

http://www.w3.org/2001/XMLSchema#string

Mark Ritter

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005

Screening and prostate-cancer mortality in a randomized European study

Contemporary risk profile of prostate cancer in the United States.

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)

Trends in the treatment of localized prostate cancer using supplemented cancer registry data.

Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.

Treatment and survival outcomes in young men diagnosed with prostate cancer: a Population-based Cohort Study

P304

97-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3121/CMR.2011.1042

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224854114

http://www.w3.org/2001/XMLSchema#string

P698

22537761

http://www.w3.org/2001/XMLSchema#string

P932

3421330

http://www.w3.org/2001/XMLSchema#string

Historical prostate cancer screening and treatment outcomes from a single institution

about

P2860

P2860

Historical prostate cancer screening and treatment outcomes from a single institution

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932